Search
for
Sort by
Research 781–810 of 1000+
- Utilization of Telemedicine in the U.S. Military in a Deployed Setting
- Is hormonal treatment still an option in acne today?
- Incidence and management of cutaneous toxicities associated with cetuximab
- Malassezia (Pityrosporon) Folliculitis Occurring During Pregnancy
- Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
- Primary Scarring Alopecias
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Folliculitis decalvans associated with erlotinib
- Feline superficial pyoderma: a retrospective study of 52 cases (2001–2011)
- Skin Barrier Dysfunction in Acne Vulgaris: Pathogenesis and Therapeutic Approaches
- Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes
- Hidradenitis Suppurativa and Wound Management
- Surgical Atlas. Primary hypospadias repair with buccal mucosa
- Molluscum folliculitis after leg shaving
- Psoriatic scarring alopecia
- Pregnancy's effects on the skin
- Facial Hidradenitis Suppurativa in a 28-Year-Old Male Responding to Finasteride
- Dermatitis cruris pustulosa et atrophicans
- Safety of skin care products during pregnancy.
- Types and Treatment of Hair Loss in Men and Women
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Dermatological problems in the football player
- Is There a Rationale for the Drugs Used in Hair Transplantation Surgery?
- Diseases of the skin. Treatment of scalp disorders.
- Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road Ahead
- Prurigo pigmentosa: A multi-institutional retrospective study
- Is low‐level laser therapy useful as an adjunctive treatment for canine acral lick dermatitis? A randomized, double‐blinded, sham‐controlled study
- Epidemiology and Management of Acne in Adult Women
- Postoperative Regimen for Chemical Peeling: A Clinical Approach
- Botulinum toxin type A for the management of hidradenitis suppurativa.